Travere Therapeutics, Inc. TVTX Asset turnover

Asset turnover at other companies

Vertex PharmaceuticalsVRTX

0.5×0.0×

Eton Pharmaceuticals, Inc.ETON

1×+0.1×

Viridian Therapeutics, Inc.VRDN

0.1×+0.1×

ANI PharmaceuticalsANIP

0.7×0.0×

PVL

Palvella TherapeuticsPVLA

0.7×+0.6×

Zevra Therapeutics, Inc.ZVRA

0.5×+0.2×

FAQ

What is Travere Therapeutics, Inc.'s asset turnover?

Travere Therapeutics, Inc. (TVTX) reported asset turnover of 1× in Q1 2026.

How has Travere Therapeutics, Inc.'s asset turnover changed year-over-year?

Travere Therapeutics, Inc.'s asset turnover increased by 115.3% year-over-year, from 0.5× to 1×.

What is the long-term trend for Travere Therapeutics, Inc.'s asset turnover?

Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s asset turnover has grown at a 25.8% compound annual growth rate (CAGR), from 0.3× to 0.8×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.